Systematic Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized Controlled Trials
- 17 June 2017
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 19 (1) , 15-22
Abstract
Background Numerous diagnostic criteria for atopic dermatitis are used in clinical trials, which may limit comparison of results. Objective We sought to determine the most commonly used atopic dermatitis diagnostic criteria in randomized controlled trials internationally. Methods We performed a systematic review of randomized controlled trials with a pharmacological intervention from 2007 to 2016. Cochrane Library, EMBASE, GREAT, LILACS, MEDLINE, and Scopus were searched. Two authors independently performed the study selection and data extraction. Results Two hundred and twelve randomized controlled trials met inclusion/exclusion criteria. Overall, ten different diagnostic criteria were used. The Hanifin and Rajka criteria were most commonly used (41.0%), followed by the UK refinement of the Hanifin and Rajka criteria (9.0%), Japanese Dermatological Association criteria (4.2%), and American Academy of Dermatology criteria (3.8%). No diagnostic criteria were specified in 37.3% of randomized controlled trials. The Hanifin and Rajka criteria were the most commonly used atopic dermatitis diagnostic criteria in clinical trials of topical and systemic interventions, across all years between 2007 and 2016, in pediatric and adult populations, in most countries and regions internationally. Conclusions The results highlight the lack of uniformity and documentation of atopic dermatitis diagnostic criteria in randomized controlled trials for atopic dermatitis. We recommend harmonizing the diagnostic criteria for atopic dermatitis in future randomized controlled trials.Keywords
Funding Information
- Agency for Healthcare Research and Quality (K12 HS023011)
- Dermatology Foundation
This publication has 28 references indexed in Scilit:
- Atopic Dermatitis Diagnostic Criteria and Outcome Measures for Clinical Trials: Still a MessJournal of Investigative Dermatology, 2011
- Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, GermanyBritish Journal of Dermatology, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Diagnostic criteria for atopic dermatitis: a systematic reviewBritish Journal of Dermatology, 2008
- Comparative efficacy of Hanifin and Rajka's criteria and the UK working party's diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North IndiaJournal of the European Academy of Dermatology and Venereology, 2006
- A comparison between criteria for diagnosing atopic eczema in infantsBritish Journal of Dermatology, 2005
- Guidelines of care for atopic dermatitisJournal of the American Academy of Dermatology, 2004
- Evaluation of diagnostic criteria for atopic dermatitis: validity of the criteria of Williams et al. in a hospital-based settingBritish Journal of Dermatology, 2001
- International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methodsEuropean Respiratory Journal, 1995
- Clinical effects of diaper types on the skin of normal infants and infants with atopic dermatitisJournal of the American Academy of Dermatology, 1987